封面
市場調查報告書
商品編碼
1800221

動物寄生蟲殺蟲劑市場-2025年至2030年的預測

Animal Parasiticides Market - Forecasts fom 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計動物寄生蟲殺蟲劑市場規模將從 2025 年的 131.9 億美元成長至 2030 年的 172.51 億美元,複合年成長率為 5.51%。

預計2025年至2030年,獸醫驅蟲劑市場將經歷顯著成長,這主要得益於寵物擁有率的上升、獸醫醫療保健成本的上漲以及人們對通用感染疾病認知的不斷提高。驅蟲劑對於控制伴侶動物和農場動物體內外寄生蟲至關重要,其需求正在成長,因為它們能夠促進動物健康並預防疾病感染。儘管嚴格的監管政策帶來了挑戰,但市場正受益於產品開發的技術創新以及政府促進動物福利的措施。

市場促進因素

獸醫殺蟲劑市場的主要驅動力是全球寵物擁有量的激增,狗和貓等伴侶動物越來越受到重視,尤其是在都市區。這種趨勢增加了對有效殺蟲劑的需求,以確保寵物健康並預防可傳播給人類的疾病。隨著寵物飼主和牲畜生產者投資先進的治療方法以改善動物福利,動物保健支出的增加(尤其是在已開發地區)進一步推動了市場成長。在政府和動物福利組織的計劃支持下,人們對動物傳播疾病的認知不斷提高也是一個關鍵因素。這類宣傳活動強調了殺蟲劑在控制由跳蚤、蜱蟲、蛔蟲和其他寄生蟲引起的疾病的重要性。此外,旨在加強伴侶動物疾病管理的創新外部殺蟲劑的開發透過提供更有效、更有針對性的解決方案來推動市場擴張。

市場限制

由於嚴格的產品核可監管政策,動物寄生蟲殺蟲劑市場面臨挑戰。這些旨在確保安全性和有效性的法規可能會延遲新型寄生蟲殺蟲劑的上市,並增加開發成本和時間。遵守不同的地區標準進一步增加了製造商(尤其是中小型企業)進入市場的難度。此外,先進寄生蟲殺蟲劑的高成本可能會限制其在價格敏感型市場(例如新興市場)的採用。透過簡化的監管流程和具有成本效益的技術創新來應對這些挑戰,對於市場持續成長至關重要。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章動物寄生蟲殺蟲劑市場(依產品類型)

  • 介紹
  • 殺外寄生蟲劑
  • 體內殺寄生蟲劑
  • Endectocides

第6章:動物寄生蟲殺蟲劑市場(以寄生蟲類型)

  • 介紹
  • 內部的
  • 外部的
    • 蜱蟲
    • 跳蚤
    • 其他

7. 動物寄生蟲防治劑市場(依給藥方式)

  • 介紹
  • 口服
  • 注射

第 8 章:動物寄生蟲殺蟲劑市場(依動物類型)

  • 介紹
  • 伴侶動物
  • 家畜
    • 家禽
    • 其他

9. 動物寄生蟲防治劑市場(按地區)

  • 介紹
  • 北美洲
    • 依產品類型
    • 依寄生蟲類型
    • 按給藥方式
    • 依動物類型
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依產品類型
    • 依寄生蟲類型
    • 按給藥方式
    • 依動物類型
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依產品類型
    • 依寄生蟲類型
    • 按給藥方式
    • 依動物類型
    • 按國家
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依產品類型
    • 依寄生蟲類型
    • 按給藥方式
    • 依動物類型
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 以色列
      • 其他
  • 亞太地區
    • 依產品類型
    • 依寄生蟲類型
    • 按給藥方式
    • 依動物類型
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章:公司簡介

  • Boehringer Ingelheim GmbH
  • Elanco
  • Virbac Corporation
  • Merck & Co., Inc.
  • Zoetis
  • Vetoquinol SA
  • Ceva Sante Animale
  • Perrigo Company Plc,
  • Norbrook Laboratories
  • Bimeda Inc.

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611764

The animal parasiticides marketis expected to grow from USD13.190 billion in 2025 to USD17.251 billion in 2030, at a CAGR of 5.51%.

The animal parasiticides market is poised for significant growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Parasiticides, critical for managing ecto- and endoparasites in companion and agricultural animals, are seeing heightened demand due to their role in enhancing animal health and preventing disease transmission. The market benefits from innovations in product development and government initiatives promoting animal welfare, though stringent regulatory policies pose challenges.

Market Drivers

The primary driver of the animal parasiticides market is the global surge in pet adoption, particularly in urban areas, where companion animals like dogs and cats are increasingly valued. This trend has amplified the demand for effective parasiticides to ensure pet health and prevent diseases transmissible to humans. Rising animal health expenditure, especially in developed regions, further fuels market growth, as pet owners and livestock producers invest in advanced treatments to improve animal welfare. Growing awareness of animal-transmitted diseases, supported by initiatives from governments and animal welfare organizations, is another key factor. These campaigns emphasize the importance of parasiticides in controlling diseases caused by fleas, ticks, worms, and other parasites. Additionally, the development of innovative ectoparasiticides, designed to enhance disease management in companion animals, is driving market expansion by offering more effective and targeted solutions.

Market Restraints

The animal parasiticides market faces challenges due to stringent regulatory policies governing product approvals. These regulations, aimed at ensuring safety and efficacy, can delay market entry for new parasiticides, increasing development costs and timelines. Compliance with diverse regional standards further complicates market access for manufacturers, particularly smaller players. Additionally, the high cost of advanced parasiticides may limit adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective innovations will be essential for sustained market growth.

Market Segmentation

By Product Type

The market is segmented into ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides, targeting external parasites like fleas and ticks, hold a significant share due to their widespread use in companion animals. Endoparasiticides, which address internal parasites like worms, are critical for both companion and agricultural animals. Endectocides, offering dual action against internal and external parasites, are gaining traction for their versatility and efficiency.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment dominates, driven by rising pet ownership and increased spending on pet healthcare. The agricultural animal segment is also significant, as parasiticides are essential for maintaining livestock health and productivity, particularly in regions with intensive farming.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by high animal health expenditure, particularly in the United States, and widespread pet adoption. The region's advanced veterinary infrastructure and effective disease management practices further support market dominance. Asia-Pacific is expected to grow rapidly, fueled by increasing pet ownership, rising livestock production, and growing awareness of zoonotic diseases in countries like China and India. Europe, South America, and the Middle East and Africa are also poised for growth, supported by improving veterinary services and regulatory frameworks.

Key Industry Players

The competitive landscape includes leading companies focused on innovation and market expansion. These players are investing in research and development to create advanced parasiticides and strengthen their market positions through strategic partnerships and product launches.

The animal parasiticides market is set for lucrative growth from 2025 to 2030, driven by rising pet adoption, increasing animal health expenditure, and growing awareness of zoonotic diseases. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective solutions and regulatory compliance to capitalize on the growing demand for parasiticides in both companion and agricultural animal sectors.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The animal parasiticides market is analyzed into the following segments:

By Product Type

  • Ectoparasiticides
  • Endoparasiticides
  • Endectocides

By Parasite Type

  • External
  • Internal

By Mode of Administration

  • Oral
  • Injectables

By Animal Type

  • Companion Animal
  • Livestock Animals

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANIMAL PARASITICIDES MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Ectoparasiticides
  • 5.3. Endoparasiticides
  • 5.4. Endectocides

6. ANIMAL PARASITICIDES MARKET BY PARASITE TYPE

  • 6.1. Introduction
  • 6.2. Internal
  • 6.3. External
    • 6.3.1. Ticks
    • 6.3.2. Fleas
    • 6.3.3. Others

7. ANIMAL PARASITICIDES MARKET BY MODE OF ADMINISTRATION

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Injectable

8. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE

  • 8.1. Introduction
  • 8.2. Companion Animals
  • 8.3. Livestock Animals
    • 8.3.1. Cattle
    • 8.3.2. Poultry
    • 8.3.3. Swine
    • 8.3.4. Others

9. ANIMAL PARASITICIDES MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Product Type
    • 9.2.2. By Parasite Type
    • 9.2.3. By Mode of Administration
    • 9.2.4. By Animal Type
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Product Type
    • 9.3.2. By Parasite Type
    • 9.3.3. By Mode of Administration
    • 9.3.4. By Animal Type
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Product Type
    • 9.4.2. By Parasite Type
    • 9.4.3. By Mode of Administration
    • 9.4.4. By Animal Type
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. France
      • 9.4.5.3. United Kingdom
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Product Type
    • 9.5.2. By Parasite Type
    • 9.5.3. By Mode of Administration
    • 9.5.4. By Animal Type
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Israel
      • 9.5.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Product Type
    • 9.6.2. By Parasite Type
    • 9.6.3. By Mode of Administration
    • 9.6.4. By Animal Type
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. India
      • 9.6.5.3. Japan
      • 9.6.5.4. South Korea
      • 9.6.5.5. Indonesia
      • 9.6.5.6. Thailand
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Boehringer Ingelheim GmbH
  • 11.2. Elanco
  • 11.3. Virbac Corporation
  • 11.4. Merck & Co., Inc.
  • 11.5. Zoetis
  • 11.6. Vetoquinol S.A.
  • 11.7. Ceva Sante Animale
  • 11.8. Perrigo Company Plc,
  • 11.9. Norbrook Laboratories
  • 11.10. Bimeda Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations